- Home
- INO vs BCIC Comparison
INO vs BCIC Comparison
Compare INO & BCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INO | BCIC |
|---|---|---|
| Founded | 1979 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.6M | 159.5M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | INO | BCIC |
|---|---|---|
| Price | $1.75 | $11.86 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 84.6K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 15.91% |
| EPS Growth | N/A | ★ 330.32 |
| EPS | N/A | ★ 1.64 |
| Revenue | $182,337.00 | ★ $58,080,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $21,214.02 | $14.87 |
| P/E Ratio | ★ N/A | $7.28 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.30 | $11.12 |
| 52 Week High | $2.98 | $17.51 |
Technical Indicators
Market Signals| Indicator | INO | BCIC |
|---|---|---|
| Relative Strength Index (RSI) | 37.10 | N/A |
| Support Level | $2.11 | N/A |
| Resistance Level | $2.37 | N/A |
| Average True Range (ATR) | 0.19 | 0.00 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 6.16 | 0.00 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About BCIC BCP Investment Corporation
BCP Investment Corp is a closed-end, externally managed, non-diversified management investment company. The company invests in performing, well- established middle market businesses that operate across a wide range of industries. It employs fundamental credit analysis, targeting investments in businesses with relatively low levels of cyclicality and operating risk.